Abstract:Although depression has been studied for many decades, the exact mechanisms that lead to depression are still unknown, and available treatments only help a fraction of patients. In the 1960s, the serotonin hypothesis was published, suggesting that serotonin is the key player in depression. However, this hypothesis is being increasingly doubted. In this review, we aim to contribute to the ongoing debate on the involvement of serotonin in depression. We review the evolution of antidepressant treatments, systemic research over the years, and future research applications that will help to bridge the gap between systemic research and neurotransmitter dynamics using biosensors. Depression is one of the most common psychiatric disorders worldwide, affecting approximately 280 million people, with probably much higher unrecorded cases. Depression is associated with symptoms such as anhedonia, feelings of hopelessness, sleep disturbances, and even suicidal thoughts. Tragically, more than 700 000 people commit suicide each year. Although depression has been studied for many decades, the exact mechanisms that lead to depression are still unknown, and available treatments only help a fraction of patients. In the late 1960s, the serotonin hypothesis was published, suggesting that serotonin is the key player in depressive disorders. However, this hypothesis is being increasingly doubted as there is evidence for the influence of other neurotransmitters, such as noradrenaline, glutamate, and dopamine, as well as larger systemic causes such as altered activity in the limbic network or inflammatory processes. In this narrative review, we aim to contribute to the ongoing debate on the involvement of serotonin in depression. We will review the evolution of antidepressant treatments, systemic research on depression over the years, and future research applications that will help to bridge the gap between systemic research and neurotransmitter dynamics using biosensors. These new tools in combination with systemic applications, will in the future provide a deeper understanding of the serotonergic dynamics in depression.

Depression research: where are we now?

Molecular Neurobiology and Promising New Treatment in Depression

The neurobiology of depression—revisiting the serotonin hypothesis. I. Cellular and molecular mechanisms

Molecular pathways of major depressive disorder converge on the synapse

The role of serotonin in depression—A historical roundup and future directions

The molecular neurobiology of depression

Revisiting the Serotonin Hypothesis: Implications for Major Depressive Disorders

From Serotonin to Neuroplasticity: Evolvement of Theories for Major Depressive Disorder

The neurobiology of depression—revisiting the serotonin hypothesis. II. Genetic, epigenetic and clinical studies

Pathogenesis of depression: Insights from human and rodent studies

Molecular Biological Aspects of Depressive Disorders: A Modern View

History and evolution of the monoamine hypothesis of depression.

Major Depressive Disorder: Advances in Neuroscience Research and Translational Applications

Understanding the pathophysiology of depression: From monoamines to the neurogenesis hypothesis model - are we there yet?

The neurobiology of depression: An integrated view

Molecular, Functional, and Structural Imaging of Major Depressive Disorder

Serotonin and beyond: therapeutics for major depression

Current advances and trends in the treatment of depression

Research on the Pathological Mechanism and Drug Treatment Mechanism of Depression

Neurobiological Investigation of Depression: Unraveling the Biological Basis of a Complex Mental Health Challenge

The role of 5-HT receptors in depression